Dynamic Technology Lab’s Pacira BioSciences PCRX Stock Holding History

Dynamic Technology Lab’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,172	Closed	-$209K	–	1280
2024 Q1	$209K	Buy	+7,172	New	+$220K	0.02%	907
2023 Q4	–	Sell	-13,476	Closed	-$414K	–	1322
2023 Q3	$414K	Buy	+13,476	New	+$486K	0.04%	549
2023 Q1	–	Sell	-12,430	Closed	-$480K	–	1417
2022 Q4	$480K	Buy	+12,430	New	+$605K	0.05%	597
2020 Q2	–	Sell	-13,420	Closed	-$450K	–	1256
2020 Q1	$450K	Buy	13,420 +7,067	+111%	+$294K	0.09%	405
2019 Q4	$288K	Buy	+6,353	New	+$270K	0.05%	693
2019 Q3	–	Sell	-8,089	Closed	-$352K	–	1206
2019 Q2	$352K	Sell	8,089 -21,323	-72%	-$905K	0.06%	569
2019 Q1	$1.12M	Buy	+29,412	New	+$1.15M	0.18%	152
2017 Q2	–	Sell	-10,105	Closed	-$461K	–	1245
2017 Q1	$461K	Buy	+10,105	New	+$437K	0.11%	345
2016 Q4	–	Sell	-9,300	Closed	-$319K	–	1093
2016 Q3	$319K	Buy	+9,300	New	+$364K	0.09%	469

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dynamic Technology Lab's PCRX Position: Q2 2024 in Review

Dynamic Technology Lab sold out of Pacira BioSciences (PCRX) in Q2 2024, closing a stake of 7,172 shares — an estimated $209K sold.

Dynamic Technology Lab first reported a position in PCRX in Q3 2016 and held it in 9 quarters. The position peaked at $1.12M in Q1 2019. 280 funds tracked by Wall St. Rank hold PCRX as of Q2 2024.

Dynamic Technology Lab reported no remaining Pacira BioSciences position as of Q2 2024 after selling out during the quarter.
Dynamic Technology Lab sold 7,172 Pacira BioSciences shares in Q2 2024, an estimated $209K.
Dynamic Technology Lab first reported a position in Pacira BioSciences in Q3 2016 and held it in 9 quarters.
Dynamic Technology Lab's Pacira BioSciences position peaked at $1.12M in Q1 2019.
280 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2024.

Based on Dynamic Technology Lab's 13F filing for Q2 2024, filed 15 Aug 2024.